Label (71610 0800 30)
This is not readable.*
Pregabalin Capsule
Product Images NDC 71610-800
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71610-800). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Aphena (Aphena)
Figure 1 (Pregabalin Fig01)
Figure 2 (Pregabalin Fig02)
Figure 3 (Pregabalin Fig03)
Figure 4 (Pregabalin Fig04)
This description is not available.*
Figure 5 (Pregabalin Fig05)
This text provides information on different medication doses given to patients (Fregabalin 100 mg, Pregataiin 80 mg, Placebo) and the improvement levels of these patients. It also includes a numerical representation showing the percentage of patients improved and the percentage of improvement in pain from the baseline.*
Figure 6 (Pregabalin Fig06)
This text provides information about a study comparing the effects of different dosages of a certain medication with a placebo. The dosages evaluated are 50mg/day, 150mg/day, 300mg/day, and 600mg/day. It mentions that there is a statistically significant difference compared to the placebo group.*
Figure 7 (Pregabalin Fig07)
Figure 9 (Pregabalin Fig08)
This text provides data on the percentage of patients improved with different doses of pregabalin (300mg and 450mg daily) compared to a placebo. It also includes a graph showing the percent improvement in pain from baseline. The graph's x-axis ranges from 210 to 280, while the y-axis shows the percent of patients improved, ranging from 0 to 100.*
Figure 10 (Pregabalin Fig09)
Figure 11 (Pregabalin Fig10)
Figure 12 (Pregabalin Fig11)
Figure 13 (Pregabalin Fig13)
The provided text contains information on responder rates of different treatment groups. It includes percentages such as 40.6%, 29.1%, and 22.6%. The comparison seems to involve a placebo and different dosage levels of a substance. The document also mentions values like 93, 103, and 9%.*
Cockcroft And Gault Equation (Pregabalin Formula)
This formula calculates the Creatinine Clearance (CLCT) based on the age and weight of the patient for males, and for females, the result is multiplied by 0.85. The formula also involves the serum creatinine level in mg/dL.*
Chemical Structure (Pregabalin Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
